Annual CFI
-$419.00 K
-$2.41 M-121.09%
31 December 2023
Summary:
Mereo BioPharma annual cash flow from investing activities is currently -$419.00 thousand, with the most recent change of -$2.41 million (-121.09%) on 31 December 2023. During the last 3 years, it has fallen by -$2.46 million (-120.57%). MREO annual CFI is now -100.74% below its all-time high of $56.77 million, reached on 31 December 2019.MREO Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$0.00
-$1000.00-100.00%
30 September 2024
Summary:
Mereo BioPharma quarterly cash flow from investing activities is currently $0.00, with the most recent change of -$1000.00 (-100.00%) on 30 September 2024. Over the past year, it has stayed the same.MREO quarterly CFI is now -100.00% below its all-time high of $1000.00, reached on 30 June 2024.MREO Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$699.00 K
$0.000.00%
30 September 2024
Summary:
Mereo BioPharma TTM cash flow from investing activities is currently -$699.00 thousand, unchanged on 30 September 2024. Over the past year, it has dropped by -$280.00 thousand (-66.83%). MREO TTM CFI is now -66.83% below its all-time high of -$419.00 thousand, reached on 21 March 2023.MREO TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MREO Cash From Investing Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -121.1% | 0.0% | -66.8% |
3 y3 years | -120.6% | - | - |
5 y5 years | -231.0% | - | - |
MREO Cash From Investing High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -120.6% | +26.3% | -100.0% | +100.0% | -66.8% | +0.1% |
5 y | 5 years | -100.7% | +26.3% | -100.0% | +100.0% | -66.8% | +0.1% |
alltime | all time | -100.7% | +91.7% | -100.0% | +100.0% | -66.8% | +0.1% |
Mereo BioPharma Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $0.00(-100.0%) | -$699.00 K(0.0%) |
June 2024 | - | $1000.00(-100.1%) | -$699.00 K(-0.1%) |
Mar 2024 | - | -$700.00 K(<-9900.0%) | -$700.00 K(+67.1%) |
Dec 2023 | -$419.00 K(-121.1%) | $0.00(0.0%) | -$419.00 K(0.0%) |
Sept 2023 | - | $0.00(0.0%) | -$419.00 K(0.0%) |
June 2023 | - | $0.00(-100.0%) | -$419.00 K(0.0%) |
Mar 2023 | - | -$419.00 K | -$419.00 K |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2022 | $1.99 M(-449.7%) | - | - |
Dec 2021 | -$568.20 K(-127.9%) | - | - |
Dec 2020 | $2.04 M(-96.4%) | - | - |
Dec 2019 | $56.77 M(>+9900.0%) | - | - |
Dec 2018 | $319.80 K(-106.3%) | - | - |
Dec 2017 | -$5.06 M(-1200.7%) | - | - |
Dec 2016 | $459.70 K | - | - |
FAQ
- What is Mereo BioPharma annual cash flow from investing activities?
- What is the all time high annual CFI for Mereo BioPharma?
- What is Mereo BioPharma annual CFI year-on-year change?
- What is Mereo BioPharma quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Mereo BioPharma?
- What is Mereo BioPharma quarterly CFI year-on-year change?
- What is Mereo BioPharma TTM cash flow from investing activities?
- What is the all time high TTM CFI for Mereo BioPharma?
- What is Mereo BioPharma TTM CFI year-on-year change?
What is Mereo BioPharma annual cash flow from investing activities?
The current annual CFI of MREO is -$419.00 K
What is the all time high annual CFI for Mereo BioPharma?
Mereo BioPharma all-time high annual cash flow from investing activities is $56.77 M
What is Mereo BioPharma annual CFI year-on-year change?
Over the past year, MREO annual cash flow from investing activities has changed by -$2.41 M (-121.09%)
What is Mereo BioPharma quarterly cash flow from investing activities?
The current quarterly CFI of MREO is $0.00
What is the all time high quarterly CFI for Mereo BioPharma?
Mereo BioPharma all-time high quarterly cash flow from investing activities is $1000.00
What is Mereo BioPharma quarterly CFI year-on-year change?
Over the past year, MREO quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Mereo BioPharma TTM cash flow from investing activities?
The current TTM CFI of MREO is -$699.00 K
What is the all time high TTM CFI for Mereo BioPharma?
Mereo BioPharma all-time high TTM cash flow from investing activities is -$419.00 K
What is Mereo BioPharma TTM CFI year-on-year change?
Over the past year, MREO TTM cash flow from investing activities has changed by -$280.00 K (-66.83%)